Claim Missing Document
Check
Articles

Found 2 Documents
Search

Analisa Minimalisasi Biaya Terapi PPI (Proton Pump Inhibitor) pada Pasien Rawat Inap Bedah di RSUD Dr. Zainoel Abidin Menggunakan Form Restriksi Suherman; Ika Wahyuningrum; Yunita Suffiana
Journal of Medical Science Vol 2 No 2 (2021): Journal of Medical Science
Publisher : LITBANG RSUDZA

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (355.881 KB) | DOI: 10.55572/jms.v2i2.59

Abstract

Based on data on the use of PPI class drugs for the last 6 months, at December 2020-May 2021 at RSUDZA, the PPI drug class is among the drugs that are widely used every year, it is also prescribed for use other than cases of gastric acid secretion disorders and hematemesis melena, it can have an impact on optimization of drug spending costs so that if the hospital cannot control the drug spending budget and it can have an impact on the hospital's cash flow. This study aims to analyze the cost minimization of PPI (proton pump inhibitor) therapy in surgical inpatients at RSUD dr. Zainoel Abidin uses a restriction form. This study is an analytical intervention study with a prospective method and based on inclusion criteria by looking at the medical records of inpatients Neurosurgery and Orthopedics in Raudhah 3,4, and 5 by filling out the research tool used is the request sheet for restriction drugs of the PPI (Proton Pump Inhibitor) class., data collection was carried out from July-October 2021 using purposive sampling. The cost analysis used in this study is CMA (Cost Minimization Analysis), Chi-Square test to see the effect between two groups of variables, Kolmogorov Smirnove normality test to analyze data normality, and Mann Whitney to see the mean difference between groups pretest-posttest. The results showed that the use of PPI therapy in this study mostly used Omeprazole 40 mg iv therapy is 98%. There was an effect of giving a PPI restriction form to decrease the frequency of using Omeprazole 40 mg iv to every 24 hours for prophylactic statistically (p<0.000). Analysis of the cost of CMA in neurosurgery patients found that there was no decrease in the cost of Omeprazole 40 mg iv therapy in the restriction form treatment group, analysis of the cost of CMA in orthopedic surgery patients found a decrease in the cost of Omeprazole 40 mg iv therapy in the treatment group using the restriction form. Factors that influence the cost analysis in this study are length of stay, types of other drug items obtained during treatment, type of surgery, and duration of use of PPI class therapy.
Penguatan Pemantauan Terapi Obat (PTO) oleh Apoteker Melalui Intervensi Aplikasi Berbasis Website dan Android desiyana, Lydia Septa Desiyana; Ika Wahyuningrum; Friska Masyitah; Hamzah, Amir
Journal of Medical Science Vol 7 No 1 (2026): Journal of Medical Science
Publisher : LITBANG RSUDZA

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55572/jms.v7i1.262

Abstract

Pemantauan Terapi Obat (PTO) merupakan salah satu tugas penting apoteker klinis untuk memastikan penggunaan obat yang aman, efektif, dan rasional. Namun, pelaksanaannya masih menghadapi kendala berupa dokumentasi manual, keterbatasan akses data, serta lamanya waktu yang dibutuhkan untuk telaah klinis. Penelitian ini bertujuan mengembangkan aplikasi PTO berbasis web dan Android guna mendukung pelayanan farmasi klinis serta meningkatkan efisiensi kerja apoteker. Penelitian menggunakan pendekatan research and development (R&D) dengan model ADDIE yang meliputi analisis kebutuhan melalui focus group discussion (FGD) pada apoteker rawat inap, perancangan sistem, pengembangan aplikasi, dan uji coba terbatas. Aplikasi yang dihasilkan diberi nama MedSIP (Medication System for Information and Monitoring Therapy) dengan fitur input data pasien terstruktur, template SOAP, serta klasifikasi drug-related problems (DRP) berbasis PCNE. Uji coba terbatas menunjukkan penurunan durasi PTO sebesar 50–55,6%, dari 40–90 menit menjadi 20–40 menit pada pasien dengan data rekam medis elektronik yang lengkap. Responden menilai aplikasi bermanfaat dalam mempercepat telaah dan dokumentasi PTO, meskipun implementasi lebih luas masih memerlukan dukungan regulasi, konsistensi input data lintas profesi, serta penguatan infrastruktur dan konektivitas jaringan. Pengembangan lanjutan dapat diarahkan pada integrasi referensi klinis, formularium rumah sakit, dan fitur auto-flagging DRP berbasis kecerdasan buatan. MedSIP berpotensi memperkuat pelayanan farmasi klinis melalui dokumentasi PTO yang lebih terstruktur dan efisien.